Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

  • L. Galluzzi
  • , S. A. Aaronson
  • , J. Abrams
  • , E. S. Alnemri
  • , D. W. Andrews
  • , E. H. Baehrecke
  • , N. G. Bazan
  • , M. V. Blagosklonny
  • , K. Blomgren
  • , C. Borner
  • , D. E. Bredesen
  • , C. Brenner
  • , M. Castedo
  • , J. A. Cidlowski
  • , A. Ciechanover
  • , G. M. Cohen
  • , V. De Laurenzi
  • , Ruggero De Maria Marchiano
  • , M. Deshmukh
  • , B. D. Dynlacht
  • W. S. El-Deiry, R. A. Flavell, S. Fulda, C. Garrido, P. Golstein, M. L. Gougeon, D. R. Green, H. Gronemeyer, G. Hajnóczky, J. M. Hardwick, M. O. Hengartner, H. Ichijo, M. Jäättelä, O. Kepp, A. Kimchi, D. J. Klionsky, R. A. Knight, S. Kornbluth, S. Kumar, B. Levine, S. A. Lipton, E. Lugli, F. Madeo, W. Malorni, J. C.W. Marine, S. J. Martin, J. P. Medema, Jan Paul Medema, P. Mehlen, G. Melino, U. M. Moll, E. Morselli, S. Nagata, D. W. Nicholson, P. Nicotera, G. Nuñez, M. Oren, J. Penninger, S. Pervaiz, M. E. Peter, M. Piacentini, J. H.M. Prehn, H. Puthalakath, G. A. Rabinovich, R. Rizzuto, C. M.P. Rodrigues, D. C. Rubinsztein, T. Rudel, L. Scorrano, H. U. Simon, H. Steller, J. Tschopp, Y. Tsujimoto, P. Vandenabeele, I. Vitale, Ilio Vitale, K. H. Vousden, R. J. Youle, J. Yuan, B. Zhivotovsky, G. Kroemer
  • Institut national de la santé et de la recherche médicale
  • Icahn School of Medicine at Mount Sinai
  • University of Texas Southwestern Medical Center
  • Thomas Jefferson University
  • McMaster University
  • University of Massachusetts Medical School
  • Louisiana State University Health Sciences Center
  • Roswell Park Cancer Institute
  • University of Gothenburg
  • University of Freiburg
  • Buck Institute for Age Research
  • UMR-S 1168
  • National Institutes of Health
  • Technion-Israel Institute of Technology
  • University of Leicester
  • Gabriele d'Annunzio University
  • University of North Carolina at Chapel Hill
  • New York University
  • University of Pennsylvania
  • Yale University
  • Ulm University
  • Lipides, Nutrition, Cancer - LNC
  • Institut Pasteur Paris
  • St. Jude Children Research Hospital
  • IGBMC Institut de Genetique et de Biologie Moleculaire et Cellulaire
  • Johns Hopkins University
  • Universität Zürich
  • The University of Tokyo
  • Danish Cancer Society
  • Weizmann Institute of Science
  • University of Michigan, Ann Arbor
  • University College London
  • Duke University
  • Hanson Institute
  • Howard Hughes Medical Institute
  • Sanford Burnham Prebys Medical Discovery Institute
  • University of Graz
  • Istituto Superiore di Sanita
  • Flanders Institute for Biotechnology
  • Trinity College Dublin
  • Academic Medical Center
  • Centre Léon Bérard
  • Stony Brook University
  • Kyoto University
  • Merck
  • Institute of Molecular Biotechnology
  • National University of Singapore
  • The University of Chicago
  • IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani - Roma
  • Royal College of Surgeons in Ireland
  • La Trobe University
  • Instituto de Biología y Medicina Experimental (IBYME-CONICET)
  • University of Padua
  • University of Lisbon
  • University of Cambridge
  • University of Würzburg
  • University of Geneva
  • University of Bern
  • University of Lausanne
  • The University of Osaka
  • University of California at San Diego
  • The Beatson Institute for Cancer Research
  • Harvard University
  • Karolinska Institutet

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Cell death is essential for a plethora of physiological processes, and its deregulation characterizes numerous human diseases. Thus, the in-depth investigation of cell death and its mechanisms constitutes a formidable challenge for fundamental and applied biomedical research, and has tremendous implications for the development of novel therapeutic strategies. It is, therefore, of utmost importance to standardize the experimental procedures that identify dying and dead cells in cell cultures and/or in tissues, from model organisms and/or humans, in healthy and/or pathological scenarios. Thus far, dozens of methods have been proposed to quantify cell death-related parameters. However, no guidelines exist regarding their use and interpretation, and nobody has thoroughly annotated the experimental settings for which each of these techniques is most appropriate. Here, we provide a nonexhaustive comparison of methods to detect cell death with apoptotic or nonapoptotic morphologies, their advantages and pitfalls. These guidelines are intended for investigators who study cell death, as well as for reviewers who need to constructively critique scientific reports that deal with cellular demise. Given the difficulties in determining the exact number of cells that have passed the point-of-no-return of the signaling cascades leading to cell death, we emphasize the importance of performing multiple, methodologically unrelated assays to quantify dying and dead cells.
Lingua originaleInglese
pagine (da-a)1093-1107
Numero di pagine15
RivistaCell Death and Differentiation
Volume16
DOI
Stato di pubblicazionePubblicato - 2009

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • Apoptosis
  • Cell Biology
  • Cell Death
  • Eukaryotic Cells
  • Flow Cytometry
  • Guidelines as Topic
  • Humans
  • Immunoblotting
  • Microscopy, Electron, Scanning
  • Microscopy, Fluorescence
  • Molecular Biology
  • Spectrometry, Fluorescence

Fingerprint

Entra nei temi di ricerca di 'Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes'. Insieme formano una fingerprint unica.

Cita questo